ARCHIVES

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 39 No. 26 | June 26, 2013

Download PDF Visit The Full Archive

Related Articles

Advisors Approve New Grant Programs In Breast Pre-Malignancy, Lung Inflammation

November 17, 2006

SEER Program Expansion Through Cost-Sharing.

March 23, 2001

NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.

May 21, 2004

Oncology Nursing Society Small Grants Available

July 19, 1996

Comprehensive Center NCAB Evaluations

June 2, 1978

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001